Perspectives and future directions for epigenetics in hematology
Open Access
- 27 June 2013
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 121 (26) , 5131-5137
Abstract
Genetic analysis of hematologic malignancies over the past 5 years has revealed abundant mutations in epigenetic regulators in all classes of disorders. Here, we summarize the observations made within our review series on the role of epigenetics in hematology. We highlight the clinical implications of mutations in epigenetic regulators and outline what we envision are some of the major areas that merit future research. Recent findings may have immediate prognostic value, but also offer new targets for drug development. However, the pleiotropic action of these regulators indicates caution is warranted and argues for investment in understanding of their underlying mechanisms of action as we proceed to exploit these findings for the benefit of patients.Keywords
This publication has 69 references indexed in Scilit:
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisNature Genetics, 2012
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- Dnmt3a is essential for hematopoietic stem cell differentiationNature Genetics, 2011
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromesLeukemia, 2011
- Inactivating mutations of acetyltransferase genes in B-cell lymphomaNature, 2011
- Cooperative Epigenetic Modulation by Cancer Amplicon GenesCancer Cell, 2010
- IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisLeukemia, 2010
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Somatic mutations of the histone H3K27 demethylase gene UTX in human cancerNature Genetics, 2009
- A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNACell, 1985